Overview
Dr. John Day, MD is a Neuromuscular Medicine Specialist, who primarily practices in Stanford, CA. He is board certified by the American Board of Psychiatry and Neurology. Dr. Day completed his residency at Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine. Dr. Day is fluent in English, Castilian, and Spanish, and is currently seeing new patients. Dr. Day’s practice accepts Aetna, Blue Cross Blue Shield (BCBS), Cigna, Humana Health, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Day’s office at (650) 723-4000.
Castle Connolly Top Doctor
Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.
Medical Specialties and Areas of Expertise
Neuromuscular Medicine Specialist
Neurologist
Education & Training
Stanford Univ Hosp, Cardiovascular Diseases; Stanford Univ Hosp, Internal Medicine (Residency)
Other Degree - Johns Hopkins Univ Sch of Med, Baltimore Md
Board Certifications
American Board of Psychiatry and Neurology
Languages
Castilian
Spanish
Medical Conditions Treated
conditions treated by a Neuromuscular Medicine Specialist, like Dr. John Day, may include:
Please contact Dr. Day's office for more information or to schedule a consultation.
Medical Procedures Performed
procedures performed by a Neuromuscular Medicine Specialist, like Dr. John Day, may include:
For detailed information, please contact Dr. Day's office.
Insurances
Top Insurances
Aetna
Blue Cross Blue Shield (BCBS)
Cigna
Humana Health
Medicaid
Medicare
View All Insurances
Locations
Recognitions
Publications
United Dystrophinopathy Project. LTBP4 genotype predicts age of ambulatory loss
JW Day
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
TURE CELL BIOLOGY, 2013
Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy
Neuromuscular disorders, 2013
Diffusion tensor imaging reveals widespread white matter abnormalities in children
JOURL OF NEUROLOGY, 2013
Diagnostic odyssey of patients with myotonic dystrophy.
Jourl of neurology
A focal domain of extreme demethylation within D4Z4 in FSHD2
NEUROLOGY, 2013
Cerebral and muscle MRI abnormalities in myotonic dystrophy
NEUROMUSCULAR DISORDERS, 2012
Clinical and genetic features of spinocerebellar ataxia type 8.
Handbook of clinical neurology, 2012
Spinocerebellar ataxia type 5.
Handbook of clinical neurology, 2012
LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy.
Anls of neurology
2010 Marigold therapeutic strategies for myotonic dystrophy.
Blonsky, K., Monckton, D., Wieringa, B., Schoser, B., Day, J. W., Enge, 2012
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy
NEUROLOGY, 2011
Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy
TURE STRUCTURAL & MOLECULAR BIOLOGY, 2011
Nonsense Mutation-Associated Becker Muscular Dystrophy
HUMAN MUTATION, 2011
White matter abnormalities and neurocognitive correlates
NEUROMUSCULAR DISORDERS, 2011
TRAUMA, TDP-43, AND AMYOTROPHIC LATERAL SCLEROSIS
MUSCLE & NERVE, 2010
Targeting parents for the treatment of pediatric obesity in boys with Duchenne muscular dystrophy
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2010
Mutatiol Spectrum of DMD Mutations in Dystrophinopathy Patients
HUMAN MUTATION, 2009
SNP Haplotype Mapping in a Small ALS Family
PLOS ONE, 2009
Congenital muscular dystrophy in a new age
NEUROLOGY, 2008
Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families
NEUROGENETICS, 2008
Heterozygosity for a protein truncation mutation of sodium channel SCN8A
JOURL OF MEDICAL GENETICS, 2006
DM2 intronic expansions
HUMAN MOLECULAR GENETICS, 2006
Spectrin mutations cause spinocerebellar ataxia type 5
TURE GENETICS, 2006
Gene symbol: SCN8A. Disease: Ataxia. Accession #Hd0520.
Human genetics, 2006
Domint non-coding repeat expansions in human disease.
Genome dymics, 2006
Genetics and molecular pathogenesis of the myotonic dystrophies.
Current neurology and neuroscience reports, 2005
R pathogenesis of the myotonic dystrophies
NEUROMUSCULAR DISORDERS, 2005
Sudden cardiac death in myotonic dystrophy type 2
NEUROLOGY, 2004
Spinocerebellar ataxia type 8
AMERICAN JOURL OF HUMAN GENETICS, 2004
Myotonic dystrophy: R pathogenesis comes into focus
AMERICAN JOURL OF HUMAN GENETICS, 2004
Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg
NEUROLOGY, 2004
Myotonic dystrophy type 2: Human founder haplotype and evolutiory conservation of the repeat tract
AMERICAN JOURL OF HUMAN GENETICS, 2003
Autoimmune rippling muscle
NEUROLOGY, 2003
Myotonic dystrophy type 2 - Molecular, diagnostic and clinical spectrum
NEUROLOGY, 2003
Molecular genetics of spinocerebellar ataxia type 8 (SCA8)
CYTOGENETIC AND GENOME RESEARCH, 2003
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
MUSCLE & NERVE, 2002
Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Current neurology and neuroscience reports, 2002
Force assessment in periodic paralysis after electrical muscle stimulation
MAYO CLINIC PROCEEDINGS, 2002
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
SCIENCE, 2001
Clinical illness due to parvovirus B19 infection after infusion of solvent
TRANSFUSION, 2000
Spinocerebellar ataxia type 8 - Clinical features in a large family
NEUROLOGY, 2000
SCA8 CTG repeat: en masse contractions in sperm and intergeneratiol sequence changes may play a
HUMAN MOLECULAR GENETICS, 2000
Clinical and genetic characteristics of a five
NEUROMUSCULAR DISORDERS, 1999
Genetic mapping of a second myotonic dystrophy locus
TURE GENETICS, 1998
Genetic manipulation of AChR responses suggests multiple causes of weakness in slow
Anls of the New York Academy of Sciences, 1998
Rapid cloning of expanded trinucleotide repeat sequences from genomic D
TURE GENETICS, 1998
Desensitization of mutant acetylcholine receptors
SYPSE, 1997
Slow-channel transgenic mice
JOURL OF NEUROSCIENCE, 1997
An improved method for muscle force neuromuscular disease assessment
JOURL OF MEDICAL ENGINEERING & TECHNOLOGY, 1996
Transgenic mouse model of the slow-channel syndrome
MUSCLE & NERVE, 1996
NICOTINIC ACETYLCHOLINE-RECEPTOR DESENSITIZATION IS REGULATED BY ACTIVATION
JOURL OF NEUROSCIENCE, 1992
NORMOCALCEMIC TETANY ABOLISHED BY CALCIUM INFUSION
ANLS OF NEUROLOGY, 1990
THUNDERCLAP HEADACHE - SYMPTOM OF UNRUPTURED CEREBRAL ANEURYSM
LANCET, 1986
TIME COURSE OF MINIATURE POSTSYPTIC POTENTIALS AT THE MAUTHNER FIBER GIANT SYPSE OF THE HATCHETFISH
BRAIN RESEARCH, 1985
POSTSYPTIC CURRENTS AT THE MAUTHNER FIBER GIANT SYPSE OF THE HATCHETFISH
BRAIN RESEARCH, 1985
POSTSYPTIC DEPRESSION OF MAUTHNER CELL-MEDIATED STARTLE REFLEX
BRAIN RESEARCH, 1980
Frequently Asked Questions
Is Dr. John Day accepting new patients?
Does Dr. John Day offer online booking?
Does Dr. John Day offer telehealth appointments?
Which language(s) does Dr. John Day speak?
Which board certifications does Dr. John Day have?
Other Neuromuscular Medicine Specialist Near Stanford, CA
SC
(650) 723-4000
Accepting patients
Accepting patientsKL
Accepting patients